Forced Oscillometry Market is expected to reach US$ 98.60 Million by 2034

Device Segment Drives Forced Oscillometry Market Growth

According to our new research study named "Forced Oscillometry Market Forecast to 2034 – Global Analysis – by Product, Application, End User, and Geography," the market was valued at US$ 62.07 million in 2025 and is projected to reach US$ 98.60 million by 2034; it is expected to register a CAGR of 5.4% during 2026–2034. The rising prevalence of respiratory diseases, the effort-independent testing advantage, and technological advancements in devices drive the adoption of forced oscillometry. Growing clinical emphasis on small airway dysfunction (SAD) detection and the rise of hybrid oscillometry systems are projected to drive forced oscillometry market trends in the coming years.

Forced oscillometry is a noninvasive pulmonary test measuring airway resistance and reactance during normal breathing, used for early detection of asthma, COPD, and monitoring lung function in children and adults. The rising prevalence of respiratory diseases such as asthma and COPD, increasing air pollution, and growing geriatric population are driving the global forced oscillometry market growth. Additionally, growing awareness of noninvasive diagnostics and demand for pediatric-friendly lung function tests are driving growth in the forced oscillometry market size. Technological advancements in oscillometry devices and rising healthcare expenditure are contributing to the rising forced oscillometry market size.

Forced Oscillometry Market, by Region, 2025 (%)

Source: The Insight Partners Analysis

Forced Oscillometry Market Analysis Based on Segmental Evaluation:

Based on product, the forced oscillometry market is segmented into device and accessories. The device segment held a significant forced oscillometry market share in 2025. The segment is experiencing substantial growth as there is an increasing need for precise noninvasive lung function testing equipment that delivers quick results. The rising incidence of respiratory diseases, which include asthma, COPD, and COVID-19-related pulmonary complications, leads medical professionals to use modern diagnostic equipment. Patients in both pediatric and geriatric age groups who experience difficulties with standard spirometry testing find it easier to use oscillometry devices. The development of portable digital devices that can connect with smartphones through their oscillometers has improved access to lung testing equipment and patient monitoring capabilities. Additionally, growing awareness among clinicians and patients about early detection and continuous lung health monitoring supports market expansion.

The geographical scope of the forced oscillometry market report encompasses an assessment of the market performance in North America, Europe, Asia Pacific, South America, Central America, the Middle East, and Africa. North America dominated the forced oscillometry market share in 2025. The growth of the market is driven by the rising prevalence of respiratory disorders such as asthma, COPD, and other obstructive airway conditions. The increasing need for advanced pulmonary diagnostic tools originates from rising air pollution levels, smoking rates, and occupational exposure to respiratory irritants. The aging population in the US and Canada creates a higher demand for noninvasive diagnostic technologies, such as forced oscillometry, as they are more susceptible to chronic respiratory diseases. Additionally, Canada maintains its strong healthcare system through its development of respiratory care services and its establishment of regulatory frameworks and its efforts to educate people about early lung function testing. The combined effects of Mexico's expanding healthcare system and its rising investments in diagnostic technology create increased demand for medical services across the region. North America controls a significant portion of the global market for forced oscillometry and related respiratory diagnostics because of its advanced technology and high disease burden and its active support of reimbursement and policy initiatives and its established diagnostic networks.

The development of portable oscillometry devices that people can easily operate, with increased medical focus on detecting small airway dysfunction, has made testing easier to access and more precise, which has resulted in hospitals and clinics across the region adopting these devices. The North American market expands as patients and healthcare providers become more aware of early disease detection and respiratory health management, which drives clinicians to find diagnostic tools that improve their confidence and patient care results, boosting forced oscillometry market growth.

The industry and clinical sectors are responding with new product innovations and partnerships through their introduction of portable oscillometry devices, which include the tremoflo C2, and through the establishment of strategic partnerships, which enable US hospitals to use oscillometry within their comprehensive respiratory diagnostic systems.

Recent advancements include forced oscillometry assessment, which determines pulmonary fibrosis in patients with Hermansky-Pudlak syndrome, as documented in a 2024 study published by the American Journal of Respiratory and Critical Care Medicine, which demonstrates benefits for severe patient disabilities. MGC Diagnostics launched the Resmon Pro Full device in 2018, and the company later enhanced the device with new clinical algorithms, which enable healthcare providers to predict COPD exacerbations and manage asthma. A 2023 review in Respiratory Medicine shows that oscillometry provides better benefits than spirometry for monitoring bronchodilator response in both children and elderly patients. Intra-breath oscillometry tracks dynamic changes, which helps clinicians identify central and peripheral obstructions through its monitoring capabilities. The current research demonstrates how oscillometry technology helps to advance respiratory treatment methods, which require no patient assistance and help medical professionals detect respiratory diseases that commonly go unrecognized in vulnerable groups. Hence, the above-mentioned factors collectively support the growth of the global forced oscillometry market.

THORASYS Thoracic Medical Systems Inc., Chest MI Inc., GANSHORN Medizin Electronic GmbH, Morgan Scientific Inc., Lothar Medical GmbH, Cognita Labs LLC, COSMED Srl, RESTECH srl, IngMar Medical, and Jaeger Medical GmbH are among the leading companies profiled in the forced oscillometry market report.

Based on product, the forced oscillometry market is bifurcated into device and accessories. By application, the market is classified into asthma, COPD, and other applications. Based on end user, the market is segmented into hospitals and clinics, diagnostic laboratories, and other end users. Geographically, the forced oscillometry market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East and Africa (Saudi Arabia, South Africa, the UAE, and the Rest of Middle East and Africa), and South and Central America (Brazil, Argentina, and the Rest of South and Central America).

Contact Us

Phone: +1-646-491-9876
Email Id: [email protected]